31 related articles for article (PubMed ID: 2158823)
1. The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.
Mongkolpathumrat P; Pikwong F; Phutiyothin C; Srisopar O; Chouyratchakarn W; Unnajak S; Nernpermpisooth N; Kumphune S
Heliyon; 2024 Jan; 10(2):e24550. PubMed ID: 38312697
[TBL] [Abstract][Full Text] [Related]
2. Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.
Baranger K; Zani ML; Labas V; Dallet-Choisy S; Moreau T
PLoS One; 2011; 6(6):e20976. PubMed ID: 21687692
[TBL] [Abstract][Full Text] [Related]
3. Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Weldon S; McNally P; McElvaney NG; Elborn JS; McAuley DF; Wartelle J; Belaaouaj A; Levine RL; Taggart CC
J Immunol; 2009 Dec; 183(12):8148-56. PubMed ID: 20007580
[TBL] [Abstract][Full Text] [Related]
4. Expression and characterization of recombinant human secretory leukocyte protease inhibitor (SLPI) protein from Pichia pastoris.
Li Z; Moy A; Sohal K; Dam C; Kuo P; Whittaker J; Whittaker M; Düzgünes N; Konopka K; Franz AH; Lin-Cereghino J; Lin-Cereghino GP
Protein Expr Purif; 2009 Oct; 67(2):175-81. PubMed ID: 19505578
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
[TBL] [Abstract][Full Text] [Related]
6. Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.
Ding A; Thieblemont N; Zhu J; Jin F; Zhang J; Wright S
Infect Immun; 1999 Sep; 67(9):4485-9. PubMed ID: 10456890
[TBL] [Abstract][Full Text] [Related]
7. Basic trypsin-subtilisin inhibitor from marine turtle egg white: hydrodynamic and inhibitory properties.
Sil PC; Chaudhuri TK; Sinha NK
J Protein Chem; 1993 Feb; 12(1):71-8. PubMed ID: 8427637
[TBL] [Abstract][Full Text] [Related]
8. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.
Boudier C; Bieth JG
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):61-8. PubMed ID: 7945266
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
Stolk J; Camps J; Feitsma HI; Hermans J; Dijkman JH; Pauwels EK
Thorax; 1995 Jun; 50(6):645-50. PubMed ID: 7638807
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activity of the C-terminal and N-terminal domains of secretory leukoprotease inhibitor in vitro.
Masuda K; Kamimura T; Watanabe K; Suga T; Kanesaki M; Takeuchi A; Imaizumi A; Suzuki Y
Br J Pharmacol; 1995 Jul; 115(6):883-8. PubMed ID: 7582515
[TBL] [Abstract][Full Text] [Related]
11. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor.
Eisenberg SP; Hale KK; Heimdal P; Thompson RC
J Biol Chem; 1990 May; 265(14):7976-81. PubMed ID: 2110563
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of antileukoprotease.
Hiemstra PS; Maassen RJ; Stolk J; Heinzel-Wieland R; Steffens GJ; Dijkman JH
Infect Immun; 1996 Nov; 64(11):4520-4. PubMed ID: 8890201
[TBL] [Abstract][Full Text] [Related]
13. Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).
Fritz H
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():79-82. PubMed ID: 3060147
[TBL] [Abstract][Full Text] [Related]
14. Role of antileukoprotease in the human lung.
Kramps JA; Rudolphus A; Stolk J; Willems LN; Dijkman JH
Ann N Y Acad Sci; 1991; 624():97-108. PubMed ID: 2064252
[No Abstract] [Full Text] [Related]
15. Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain.
Kramps JA; van Twisk C; Appelhans H; Meckelein B; Nikiforov T; Dijkman JH
Biochim Biophys Acta; 1990 Apr; 1038(2):178-85. PubMed ID: 2158823
[TBL] [Abstract][Full Text] [Related]
16. The location of inhibitory specificities in human mucus proteinase inhibitor (MPI): separate expression of the COOH-terminal domain yields an active inhibitor of three different proteinases.
Meckelein B; Nikiforov T; Clemen A; Appelhans H
Protein Eng; 1990 Jan; 3(3):215-20. PubMed ID: 2158659
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
